Rationale and design of a randomized clinical trial to assess the safety and efficacy of multipoint pacing therapy: MOre REsponse on Cardiac Resynchronization Therapy with MultiPoint Pacing (MORE-CRT MPP-PHASE II)

Autor: Leclercq, Christophe, Burri, Haran Kumar, Curnis, Antonio, Delnoy, Peter Paul, Rinaldi, Christopher A, Sperzel, Johannes, Lee, Kwangdeok, Cohorn, Clay, Thibault, Bernard, MORE-CRT MPP Investigators

Publikováno v: American Heart Journal
American Heart Journal, Elsevier, 2019, 209, pp.1-8. ⟨10.1016/j.ahj.2018.12.004⟩
American Heart Journal, 2019, 209, pp.1-8. ⟨10.1016/j.ahj.2018.12.004⟩
American Heart Journal, Vol. 209 (2019) pp. 1-8

International audience; BACKGROUND: Although cardiac resynchronization therapy (CRT) is beneficial in most heart failure patients, up to 40% do not respond to CRT. Data from the MultiPoint Pacing (MPP) IDE trial and MORE-CRT MPP-PHASE I study suggest

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75c3080c6f4a066c9badce6ebc734e18
https://pubmed.ncbi.nlm.nih.gov/30616009

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.